Strides Pharma infuses Rs 15.50 crore in Fairmed for 70pc stake
The company's step-down subsidiary Strides Pharma Global has acquired a majority stake in Fairmed Healthcare AG which has a portfolio of generic products encompassing prescription and over-the-counter drugs across several therapeutic segments.
NEW DELHI: Strides Pharma Science on Wednesday said it has acquired 70% stake in Switzerland-based Fairmed Healthcare AG for CHF 2.2 million (over 15.50 crore).
The company's step-down subsidiary Strides Pharma Global has acquired a majority stake in Fairmed Healthcare AG which has a portfolio of generic products encompassing prescription and over-the-counter drugs across several therapeutic segments, Strides Pharma said in a statement.
Read Also: Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore
"Under the terms of the agreement, Strides Pharma Global Pte will hold 70% of the issued capital of Fairmed. Strides Pharma has infused CHF (Swiss franc) 2.2 million into the entity in lieu of the equity stake," it added.
The acquisition further strengthens Strides' footprint in continental Europe, it said.
Read Also: Strides Pharma gets zero USFDA observations for Alathur facility
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd